Trial Profile
Effects of an alpha2 adrenergic agonist and a beta adrenergic antagonist on disturbance of visual function in glaucoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary) ; Timolol (Primary)
- Indications Glaucoma; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Senju Pharmaceutical
- 10 Jan 2022 Status changed from active, no longer recruiting to completed.
- 10 Jun 2016 New trial record